Müller, M.; Lintener, H.; Henkel, V.; Pilz, A.; Halsby, K.; Malerczyk, C.; Madhava, H.; Moïsi, J.C.; Yu, H.; Schley, K.
Does the Vaccination against Tick-Borne Encephalitis Offer Good Value for Money for Incidence Rates below the WHO Threshold for Endemicity? A Case Study for Germany. Vaccines 2024, 12, 1165.
https://doi.org/10.3390/vaccines12101165
AMA Style
Müller M, Lintener H, Henkel V, Pilz A, Halsby K, Malerczyk C, Madhava H, Moïsi JC, Yu H, Schley K.
Does the Vaccination against Tick-Borne Encephalitis Offer Good Value for Money for Incidence Rates below the WHO Threshold for Endemicity? A Case Study for Germany. Vaccines. 2024; 12(10):1165.
https://doi.org/10.3390/vaccines12101165
Chicago/Turabian Style
Müller, Malina, Hannah Lintener, Vivien Henkel, Andreas Pilz, Kate Halsby, Claudius Malerczyk, Harish Madhava, Jennifer C. Moïsi, Holly Yu, and Katharina Schley.
2024. "Does the Vaccination against Tick-Borne Encephalitis Offer Good Value for Money for Incidence Rates below the WHO Threshold for Endemicity? A Case Study for Germany" Vaccines 12, no. 10: 1165.
https://doi.org/10.3390/vaccines12101165
APA Style
Müller, M., Lintener, H., Henkel, V., Pilz, A., Halsby, K., Malerczyk, C., Madhava, H., Moïsi, J. C., Yu, H., & Schley, K.
(2024). Does the Vaccination against Tick-Borne Encephalitis Offer Good Value for Money for Incidence Rates below the WHO Threshold for Endemicity? A Case Study for Germany. Vaccines, 12(10), 1165.
https://doi.org/10.3390/vaccines12101165
